Neulasta Biosimilar: Smooth Patent Dance, Stumble On Launch Notification
Amgen patent infringement suit follows information exchange with Apotex; Federal Circuit’s ruling on commercial notification to be tested.
Amgen patent infringement suit follows information exchange with Apotex; Federal Circuit’s ruling on commercial notification to be tested.